课题基金 / 基金详情

ENALAPRIL FOR POSTTRANSPLANT ERYTHROCYTOSIS

ENALAPRIL FOR POSTTRANSPLANT ERYTHROCYTOSIS
依那普利治疗移植后红细胞增多症
批准号:
3783536
负责人:
ROBERT S GASTON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

ROBERT S GASTON的其他基金

相关文献

中文摘要
翻译
移植后红细胞增多症(PTE)折磨5-15%的患者
英文摘要
Posttransplant erythrocytosis (PTE) afflicts 5-15% of those patients with successful renal transplants. In an uncontrolled trial, we have established that enalapril is effective in normalizing hematocrits in patients with PTE. This trial is designed to evaluate the efficacy & hormonal effects of enalapril in such patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENALAPRIL FOR POSTTRANSPLANT ERYTHROCYTOSIS
L-ARGININE IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT PATIENTS
L-ARGININE IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT PATIENTS
ISRADIPINE AND NIFEDIPINE ON SODIUM EXCRETION IN RENAL ALLOGRAFT